NCT05061654 2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4 Withdrawn
Clinical Trials
3 trialsNCT02895529 2019-05-06
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
Xian-Janssen Pharmaceutical Ltd.
Phase 4 Terminated
NCT00067730 2007-12-07
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
Eli Lilly and Company
Phase 4 Completed